A comparative study on the usefulness of midazolam and pethidine in esophagogastroduodenoscopy

A comparative study on the usefulness of midazolam and pethidine in esophagogastroduodenoscopy - A comparative study on the usefulness of midazolam and pethidine in esophagogastroduodenoscopy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022087

Enrollment

Registered

2016-04-27

Start date

2016-04-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients requiring upper gastrointestinal endoscopy

Interventions

esophagogastroduodenoscopy with midazolam esophagogastroduodenoscopy with pethidine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients evaluated by esophagogastroduodenoscopy

Exclusion criteria

Exclusion criteria: patients with midazolam or pethidine allergy. patients who have been judged as inappropriate for this study

Design outcomes

Primary

Measure	Time frame
The percentage of patients whose esophagogastric junction could be observed circumferentially	—

Secondary

Measure	Time frame
The tolerability of the examination, duration of the examination, procedural accidents, number of neoplastic lesions detected, and with/without sufficient observability of the lower pharynx	—

Countries

Japan

Contacts

Public ContactYasumasa Matsuo

St. Marianna University School of Medicine Gastroenterology and hepatology division

yasumasa_matsuo@marianna-u.ac.jp0449778111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026